May 24, 2022
U.S. FDA Approves Monkeypox Treatment Formulation
By Mark Rubinshtein (May 25, 2022) SIGA Technologies Inc., a New York-based pharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) for an intravenous formulation of...
